Publication | Closed Access

Intensive postremission therapy in adults with acute nonlymphocytic leukemia using various dose schedules of ara-C: a progress report from the CALGB. Cancer and Leukemia Group B.

Critical Care ManagementHematological MalignancyMedicineAcute CareHematologyLeukemia Group BPharmacotherapyVarious Dose SchedulesIntensive Postremission TherapyOncologyRadiation OncologyHealth Sciences